|
⚲
|
| Keyboard |
| Thorp Clay
✚
|
|
|---|---|
| CIK # | 0001592380 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001592380] | |
| 4 | [0001592380] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Clearside Biomedical Inc CLSD
Common Stock
|
2025-02-24 | Buy | 15,000 | $0.92 | 13,800 |
|
Clearside Biomedical Inc CLSD
Stock Option (right to buy) · derivative
|
2024-06-20 | Grant | 45,000 | $0.00 | |
|
Clearside Biomedical Inc CLSD
Common Stock
|
2023-09-25 | Buy | 10,000 | $0.86 | 8,600 |
|
Clearside Biomedical Inc CLSD
Stock Option (right to buy) · derivative
|
2023-06-22 | Grant | 30,000 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2023-05-19 | Option exercise | 3,750 | ||
|
PhaseBio Pharmaceuticals Inc PHAS
Restricted Stock Units · derivative
|
2023-05-19 | Option exercise | 3,750 | $0.00 | |
|
Clearside Biomedical Inc CLSD
Common Stock
|
2022-12-21 | Buy | 14,000 | $1.02 | 14,280 |
|
Clearside Biomedical Inc CLSD
Common Stock
|
2022-12-15 | Other | 8,522 | $0.00 | |
|
Clearside Biomedical Inc CLSD
Common Stock
|
2022-12-15 | Other | 1,406,507 | $0.00 | |
|
Clearside Biomedical Inc CLSD
Stock Option (right to buy) · derivative
|
2022-06-22 | Grant | 30,000 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Restricted Stock Units · derivative
|
2022-05-19 | Grant | 3,750 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Non-employee Director Stock Option (right to buy) · derivative
|
2022-05-19 | Grant | 17,500 | $0.00 | |
|
Vigil Neuroscience Inc VIGL
Common Stock
|
2022-05-17 | Buy | 14,893 | $2.97 | 44,232 |
|
Vigil Neuroscience Inc VIGL
Common Stock
|
2022-05-16 | Buy | 21,802 | $2.76 | 60,174 |
|
Vigil Neuroscience Inc VIGL
Common Stock
|
2022-03-28 | Buy | 3,000 | $7.20 | 21,600 |
|
Vigil Neuroscience Inc VIGL
Common Stock
|
2022-01-11 | Buy | 265,000 | $14.00 | 3,710,000 |
|
Vigil Neuroscience Inc VIGL
Series B Preferred Stock · derivative
|
2022-01-11 | Conversion | 926,506 | $0.00 | |
|
Vigil Neuroscience Inc VIGL
Series A Preferred Stock · derivative
|
2022-01-11 | Conversion | 2,552,021 | $0.00 | |
|
Vigil Neuroscience Inc VIGL
Common Stock
|
2022-01-11 | Conversion | 1,254,335 | ||
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2021-08-18 | Buy | 10,000 | $3.00 | 30,000 |
| showing 20 of 179 most recent transactions | |||||